AZ sues McKesson over inflated drug prices
The state of Arizona has filed a lawsuit against McKesson Corp., alleging the nation's largest drug wholesaler has artificially inflated the prices of more than 400 brand-name prescription drugs. Among the drugs that are alleged to have been marked-up inappropriately are: Allegra, Azmacort, Celebrex, Coumadin, Flonase, Lipitor, Neurontin, Nexium, Prevacid and Valium. The complaint was filed in Maricopa County Superior Court, alleging that the scheme began in 2000 to mark up the average wholesale price of many prescription drugs, costing consumers millions of dollars, according to Arizona Attorney General Tom Horne. The San Francisco company controls about one-third of the national wholesale drug distribution market, Horne said.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Transforming Cancer Care
- Acute Kidney Injury Gets New Focus
- Interventional Radiology No Longer a Sub-Specialty
- Sharp HealthCare Leaves Pioneer ACO Program
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Report: Enrollees still face account problems on Healthcare.gov
- MA an Insurance Proving Ground for Providers